ALK-Positive Non-Small Cell Lung Cancer Overview

Save information for later
Sign Up

Learn About ALK-Positive Non-Small Cell Lung Cancer

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top ALK-Positive Non-Small Cell Lung Cancer Local Doctors?
Thoracic Surgery
Thoracic Surgery

Cardiothoracic Surgeons Inc

545 Barnhill Dr, Eh215, 
Indianapolis, IN 
 1.2 mi
Accepting New Patients

Chadrick Denlinger is a Thoracic Surgeon in Indianapolis, Indiana. Dr. Denlinger and is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Esophageal Perforation, Pleuropulmonary Blastoma, Endoscopy, and Gastrostomy. Dr. Denlinger is currently accepting new patients.

Hematology Oncology | Hematology | Oncology
Hematology Oncology | Hematology | Oncology

University Medical Diagnostic Associates Inc

535 Barnhill Dr, 
Indianapolis, IN 
 1.2 mi
Accepting New Patients
Offers Telehealth

Shadia Jalal is a Hematologist Oncology specialist and a Hematologist in Indianapolis, Indiana. Dr. Jalal and is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Pleuropulmonary Blastoma. Dr. Jalal is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Intensive Care Medicine | Hematology | Oncology
Intensive Care Medicine | Hematology | Oncology

University Medical Diagnostic Associates Inc

535 Barnhill Dr, 
Indianapolis, IN 
 1.2 mi
Accepting New Patients

Ahmad Al-Hader is an Intensive Care Medicine specialist and a Hematologist in Indianapolis, Indiana. Dr. Al-Hader has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Al-Hader is currently accepting new patients.

What are the latest ALK-Positive Non-Small Cell Lung Cancer Clinical Trials?
Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)

Summary: The goal of this clinical research study is to learn if the combination of brigatinib and either local consolidation therapy (such as radiotherapy or surgery) or chemotherapy (pemetrexed and carboplatin) can help to control the disease compared with brigatinib alone. The safety of these combinations will also be studied.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Real-World Study to Evaluate the Effectiveness and Safety of Brigatinib in First Line in Patients With ALK Positive Locally Advanced or Metastatic NSCLC in China: An Ambispective, Non-interventional, Observational, Multi-center Study.

Summary: The main aim of this study is to learn about the time between the start and stop of treatment with brigatinib in Chinese participants with non-small-cell lung cancer (NSCLC) and who have been positively diagnosed with having the anaplastic lymphoma kinase (ALK) gene. Other study aims are to learn about the progression of NSCLC and participants' response to treatment with brigatinib.